the aid library

LIST OPTIONS

Filter

8940

Download (447)

View PDF (922)

NATIONAL FAMILY PLANNING GUIDELINES FOR SERVICE PROVIDERS

Division of Reproductive Health Ministry of Public Health and Sanitation, Kenya (2010) C2

Updated to Reflect the 2009 Medical Eligibility Criteria of the World Health Organization

Download (382)

View PDF (539)

Annual household survey 2015/2016 (Major findings). Nepal

Central Bureau of Statistics, National Planning Commission Government of Nepal, UNDP (2016) C1

Annual Household Survey 2015/16 is the forth survey of its kind. These annual surveys are conducted to provide estimations of some major socio-economic indicators on annual basis which would not be possible with other periodic surveys like Nepal Labour Force Surveys (NLSS) and Nepal Living Standard ... more

Download (840)

View PDF (769)

World Malaria Report 2021

World Health Organization WHO (2021) C_WHO

TNew data from the World Health Organization reveal that the COVID-19 pandemic has disrupted malaria services, leading to a marked increase in cases and deaths. According to WHO’s latest World malaria report, there were an estimated 241 million malaria cases and 627 000 malaria deaths worldwide i... more

Download (638)

View PDF (1178)

Education for all national review report 2001-2015: National Review Report Nepal

Government of Nepal Ministry of Education Department of Education (2015) C1

Download (502)

View PDF (735)

Ethiopia: Report on the Sentinel Surveillance of Sexually Transmitted Infections Based on Syndromic Case Reporting (July 2014-June 2015)

The Ethiopian Public Health Institute, Federal Ministry of Health Ethiopia (2015) C_CDC

Download (494)

View PDF (652)

Rwanda: MOH GUIDELINES ON SUBMISSION OF DOCUMENTATION FOR REGISTRATION OF HUMAN PHARMACEUTICAL PRODUCTS

Ministry of Health, Rwanda (2014) C2

These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and Registration (MER) of the East African Community M... more

Download (432)

View PDF (485)

Global Status Report on Disability and Development. Prototyp 2015

United Nations Department of Economic and Social Affairs (DESA) (2015) CC

This report situates disability and inclusion within the broader context of sustainable development, with a particular focus on the Sustainable Development Goals (SDGs). The paper provides background on the historical role of the UN in promoting inclusion and outlines the current trends and challeng... more

Download (885)

View PDF (871)

Antidepressants (Tricyclic Antidepressants and Selective Serotonin Reuptake Inhibitors) in treatment of adults with depression

World Health Organization WHO (2012) C_WHO

Q 1: Are antidepressants (Tricyclic Antidepressants (TCA) and Selective Serotonin Reuptake Inhibitors (SSRI)) better (more effective than/as safe as) than treatment as usual (placebo) in adults with depressive episode/disorder?

Download (509)

View PDF (871)

Malawi MDG Endline Survey 2014

National Statistical Office of Malawi; UNICEF; WHO; et al. (2015)

Download (143)

View PDF (159)

Implementation guidance for assessments of frontline service readiness: strengthening real-time monitoring of health services in the context of the COVID-19 pandemic, 1 July 2021

World Health Organization WHO (2021) C_WHO

External Link

Antimicrobial Resistance: Challenges and Perspectives

Doyle, M.P.; G. H. Loneragan, H. M. Scott et al. (2006) C2

Comprehensive Reviews in Food Science and Food Safety, Vol.12 (2013) pp.234-248 In 2006, the Institute of Food Technologists (IFT) published an Expert Report entitled “Antimicrobial Resistance: Implications for the Food System” (IFT 2006). That report summarized current scientiﬁc knowledge pe... more

External Link

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Kenya

Africa Center for Disease Control and Prevention (2023) CC

The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr... more

Download (146)

View PDF (190)

The Georgian national HIV/AIDS strategic plan for 2016–2018

CCM Georgia (2019) C2

Endorsed by the CCM Georgia on April 15th 2015 Accessed: 26.09.2019

Download (347)

View PDF (557)

Living Conditions among People with Activity Limitations in Zambia: A National Representative Study.

Arne H Eide & ME Loeb SINTEF Health Research (2006) C1

This research report provides results from the study on living conditions among people with disabilities in Zambia. Comparisons are made between individuals with and without disabilities and also between households with and without a disabled family member. Results obtained in Zambia are also compar... more

Download (316)

View PDF (307)

Saving Mothers, Giving Life. Maternal Mortality Endline Census in Selected Districts

Central Statistical Office (CSO) Zambia, Ministry of Health (MOH) Zambia, and ICF, et al. (2017) C1

Download (73)

View PDF (61)

South Africa - Country Cooperation Strategy 2023 - 2027

World Health Organization WHO (2025) C_WHO

The South African WHO Country Cooperation Strategy (CCS) 2023–2027 focuses on four key strategic priorities based on the country’s health needs and disease epidemiology, while also considering the need for building resilient health systems for UHC and health security in the post pandemic period.... more

Download (335)

View PDF (446)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (286)

View PDF (222)

Interventions for preventing child abuse

World Health Organization (2012) C_WHO

Q2: What are the effective interventions for preventing child abuse and its mental health consequences?

Download (670)

View PDF (858)

Brief, structured psychological treatment

World Health Organization WHO (2012) C_WHO

Q 3: Is brief, structured psychological treatment in non-specialist health care settings better (more effective than/as safe as) than treatment as usual in people with depressive episode/disorder?

Download (252)

View PDF (344)

Rules of engagement between the UN and private actors - Towards a regulatory and institutional framework

Jens Martens and Karolin Seitz MSEREOR, Brot für die Welt, Global Policy Forum Europe (2019) C2

This working paper aims to provide a rough over-view of existing rules and guidelines on the coopera-tion between the UN and the private sector – at least as they are publicly available. It will describe com-mon features and discuss advances and shortcomings of the most prominent a... more